6 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
An overview of immune checkpoint inhibitors in breast cancer
Federica Miglietta ... Nicla La Verde
Published: December 28, 2020 Explor Target Antitumor Ther. 2020;1:452–472
This article belongs to the special issue Immunotherapy in Cancer Patients
Open Access
Review
Circulating biomarkers in malignant pleural mesothelioma
Giuseppe Viscardi ... Giulia Galli
Published: December 28, 2020 Explor Target Antitumor Ther. 2020;1:434–451
This article belongs to the special issue Liquid Biopsy in Thoracic Cancer
Open Access
Letter to the Editor
Is hyperprogressive disease a specific phenomenom of immunotherapy?
Marta Brambilla ... Mario Occhipinti
Published: December 28, 2020 Explor Target Antitumor Ther. 2020;1:427–433
This article belongs to the special issue Immunotherapy in Cancer Patients
Open Access
Review
An overview of the potential anticancer properties of cardamonin
Shanaya Ramchandani ... Manoj Garg
Published: December 28, 2020 Explor Target Antitumor Ther. 2020;1:413–426
This article belongs to the special issue Targeting Transcription Factors for Cancer Therapy
Open Access
Review
Targeting transcription factors in cancer drug discovery
Partha Mitra
Published: December 28, 2020 Explor Target Antitumor Ther. 2020;1:401–412
This article belongs to the special issue Targeting Transcription Factors for Cancer Therapy
Open Access
Review
Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC
Marialucia Iacovino ... Francesca Sparano
Published: December 28, 2020 Explor Target Antitumor Ther. 2020;1:391–400
This article belongs to the special issue Liquid Biopsy in Thoracic Cancer
